Esperion Therapeutics (ESPR) Change in Inventory (2020 - 2026)

Esperion Therapeutics' Change in Inventory history runs 7 years deep, the most recent figure standing at -$915000.0 for Q1 2026.

• Quarterly Change in Inventory fell 118.94% year-over-year to -$915000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 81.37% YoY) and the FY2025 annual result came in at $10.6 million, down 63.17% from the prior year.
• Change in Inventory was -$915000.0 for Q1 2026 at Esperion Therapeutics, up from -$3.4 million in the prior quarter.
• Across five years, Change in Inventory topped out at $15.1 million in Q2 2025 and bottomed at -$6.4 million in Q2 2022.
• A 5-year average of $4.1 million and a median of $4.8 million in 2025 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2022 — Change in Inventory sank 274.32% — and 2023, when it jumped 1739.94%.
• Esperion Therapeutics' Change in Inventory stood at $5.7 million in 2022, then surged by 150.85% to $14.2 million in 2023, then climbed by 1.42% to $14.4 million in 2024, then plunged by 123.73% to -$3.4 million in 2025, then jumped by 73.21% to -$915000.0 in 2026.
• Business Quant data shows ESPR's Change in Inventory at -$915000.0 in Q1 2026, -$3.4 million in Q4 2025, and -$5.9 million in Q3 2025.